logo
Share SHARE
FONT-SIZE Plus   Neg

Genmab: Daratumumab Granted Fast Track Designation By FDA - Quick Facts

Genmab A/S (GNMSF.PK) announced that the US Food and Drug Administration has granted Fast Track designation for daratumumab. This designation covers patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD) or are double refractory to a PI and an IMiD.

In August 2012, Genmab granted Janssen Biotech, Inc. an exclusive worldwide license to develop and commercialize daratumumab.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Credit Suisse Group AG were gaining around 4 percent in the morning trading in Zurich after the Swiss banking giant reported Wednesday a profit in its first quarter, compared to a loss last year, with significant growth in revenues. The company also announced its plans to raise approximately 4 billion francs capital through a fully underwritten rights offering. Live-streaming video platform Twitch said it will launch a new affiliate program for non-partnered streamers that will allow them to earn money as they broadcast on the platform. This will be similar to YouTube's Partner program and is part of Twitch's efforts to broaden its appeal. Chocolate company Hershey Co. said it will increase the visibility of nutrition information and portion options of its snacks as well as reduce the sweets' calorie count. The move is part of the company's ongoing efforts to offer a broad range of snacks and clear information in response to feedback from consumers, who are shifting to healthier foods.
comments powered by Disqus
Follow RTT